Top Markets
#1 Purr Purr +32.88%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +32.33%
#3 Siren Siren +30.36%
#4 OriginTrail OriginTrail +22.45%
#5 ApeX ApeX +19.17%
#6 UnifAI Network UnifAI Network +18.04%
#7 Unit Plasma Unit Plasma +17.45%
#8 Plasma Plasma +17.45%
#9 Wrapped XPL Wrapped XPL +17.45%
#10 Morpho Morpho +16.16%
Coin of the day
Purr Purr
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Sudarshan Pharma Industries Ltd. Sudarshan Pharma Industries Ltd.

Sudarshan Pharma Industries Ltd.

SUDARSHAN
Kedudukan dalam Saham #21543
Sudarshan Pharma Industries Ltd. operates as a supplier of specialty chemicals,... Sudarshan Pharma Industries Ltd. operates as a supplier of specialty chemicals, intermediates, and active pharmaceutical ingredients. The company strategically sources its products externally to cater to clients both within India and internationally. Additionally, the firm is active in contract manufacturing and provides outsourced generic pharmaceutical formulations and various medicines. These are supplied to a broad spectrum of clients, including healthcare institutions, governmental agencies, non-profit organizations, and hospitals. Established on July 23, 2008, Sudarshan Pharma maintains its corporate headquarters in Mumbai, India.
Harga Saham
$0.42123944
Disegerakkan terakhir: 2026-08-21
Modal Pasaran
$105.17M
Perubahan (1 hari)
-0.57%
Perubahan (1 tahun)
5.80%
Negara
IN
Perdagangan Sudarshan Pharma Industries Ltd. (SUDARSHAN)

Kategori

Healthcare
Pendapatan untuk Sudarshan Pharma Industries Ltd. (SUDARSHAN)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Sudarshan Pharma Industries Ltd., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Sudarshan Pharma Industries Ltd. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT